Tracleer (Bosentan), Oral Treatment For Pulmonary Arterial Hypertension, Available In US
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Tracleer (Bosentan), Oral Treatment For Pulmonary Arterial Hypertension, Available In US

ALLSCHWIL, SWITZERLAND -- December 5, 2001 -- Actelion Ltd. announced the commercial availability in the United States of Tracleer™ (bosentan), an orally active endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH).

Tracleer, approved by the U.S. Food and Drug Administration on November 20, 2001, is indicated to improve exercise ability and decrease the rate of clinical worsening in PAH patients with significant limitation of physical activity (WHO Class III and IV). PAH is a chronic, life-threatening disorder that can severely compromise the function of the lungs and heart.

Tracleer is available in bottles of 60 tablets in strengths of 62.5 mg and 125 mg through a limited group of four specialty pharmacy distributors: Caremark Inc., Gentiva Health Services, Nova Factor Inc. and Procare Pharmacy Inc.

Approximately 11 percent of patients receiving Tracleer experienced abnormal, but reversible liver enzyme elevations. It is therefore important that patients undergo monthly liver monitoring. Due to the risk of birth defects, women who are pregnant, or may become pregnant, cannot take Tracleer. Monthly pregnancy tests are required for woman of child-bearing potential.

SOURCE Actelion Ltd.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities